AzTrials
AzTrials

ObesityEBUNCT03213717

Effect of Body Weight Loading on Urinary Electrolyte Excretion

A study testing Heavy Casall HIT weight vest, Standing and Water load in people with Obesity and Edema, run by Göteborg University at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Title: Effect of body weight loading on urinary electrolyte excretion Swedish Title: Effekt av belastning på utsöndring av elektrolyter Study period: Q2-Q3 2017 Study site: The study will be performed at the Institution for Neurology and Physiology, Sahlgrenska Academy, University of Gothenburg. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Obesity, Edema
What is being tested?
Heavy Casall HIT weight vest, Standing and Water load
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
1 siteSweden
Study dates
13 Jun 2017to 4 Jul 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • For inclusion in the study, subjects must fulfil the following criteria:
  • Healthy volunteers
  • Signed informed consent
  • Willingness to comply with study restrictions of not using alcohol, coffee etc during the hours specified below prior to each study day

Who cannot join

  • Subjects must not enter the study if any of the following are present:
  • Chronic disease requiring continuous medication or harden the participation in the study as judged by the investigator
  • High blood pressure (>140/90 mm Hg)
  • Chronic pain such as pain that is constant and impairs quality of life
  • Consumption of medications during the last 7 days prior the study day, not including contraceptives
  • Consumption of nature medicine or supplements that results in a increased intake of a specific compound that isn't a nutrient during the last 7 days prior the study day
Show all 11Show fewer
  • Smoking, snuff use or intake of drugs during the last 7 days prior the study day
  • Intake of alcohol during the last 24 hours prior the study day
  • Intake of coffee and tea during the last 12 hours prior the study day
  • Strenuous physical activity before the study during the last 6 hours prior the study day
  • Pregnancy: Females of childbearing potential must confirm to use reliable contraception and not suspect to be pregnant

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • University of Gothenburg

    Gothenburg, Box 100, S-405 30

Other trials in Sweden

About this study

Title: Effect of body weight loading on urinary electrolyte excretion

Swedish Title: Effekt av belastning på utsöndring av elektrolyter

Read more

Study period: Q2-Q3 2017

Study site: The study will be performed at the Institution for Neurology and Physiology, Sahlgrenska Academy, University of Gothenburg. Principal Investigator is John-Olov Jansson, MD, PhD, Professor at Institute of Neuroscience and Physiology, University of Gothenburg

Background and study design: Weight reduction can be obtained by decreased appetite or increased metabolism. However, acute weight loss can also be obtained by loss of fluids - for example by increased urinary loss of fluid and salts, so called elctrolytes. Preliminary results from a laboratory lesson for the Master of Science in Medicine program at University of Gothenburg suggest that carrying a 10 kg weight vest could increase urinary excretion of Na+, K+ and Cl-. The purpose of this study is to investigate this further in a more controlled research setting. If confirmed, the results could potentially contribute to the development of potent diuretics or obesity medicines.

The study will include 15 healthy volunteers and consist of three study days with about one week between each study day. The study subjects will go through a different study procedure each study day, and a randomized cross-over study design will be used to determine which procedure each day.

Procedure 1: Wearing a weight vest with 10 % of body weight standing for seven hours. The study subject is allowed to sit for 10 minutes each hour. The reason for this is that it has been considered that the effect may be transmitted by weight loading of the lower extremities.

Procedure 2: Wearing a weight vest with 1 % of body weight standing for seven hours, as a control for procedure 1, with lower loading. The study subject is allowed to sit for 10 minutes each hour.

Procedure 3: Wearing a weight vest with 1 % of body weight sitting for seven hours. This is a procedure with even less loading of the lower extremities than during procedure 2.

Urine- and blood samples, as well as heart rate and blood pressure measurements, will be collected during the study days and analyzed in order to address the primary and secondary objectives of the study.

Read the detailed description
  1. INTRODUCTION 1.1. Background Weight reduction can be obtained by decreased appetite or increased metabolism. However, acute weight loss can also be obtained by loss of fluids - for example, urinary loss. The last of these effects was investigated during 2016. The medical education at The Sahlgrenska Academy in Gothenburg offers in its third semester a student lab called "Vattenbalans" [=Water balance]. The purpose of this lab is to study fluid loss by the kidneys. In total more than 120 students participate, although the urine flow rate is only measured on approximately 50 students each semester. The rest of the students function as secretaries. The lab protocol can be found in "Komplett-laborationskompendium-T2-T3-uppdaterat-150318" pp. 123-134. In summary a total of 50 students wore a weight west. Half of the students wore a 10 kg weight vest and half of the students wore a 1 kg weight vest. The study lasted for four hours. The students were only allowed to sit a maximum of 10 minutes during each hour. No significant difference was observed in urine flow rate. Surprisingly however, the investigators found that the students who wore a 10 kg weight vest excreted more electrolytes than those wearing a 1 kg weight vest. In the group free from treatment (see below) only consisted of 13 subjects and the investigators were therefore not able to obtain significant results (p=0,088). The investigators believe that with a larger study population and better matched controls the investigators will reach significant results. It shall be noted that these results were obtained during a student lab with a fixed protocol. In addition to wearing a weight vest the students also received one of the following treatments: one liter of water orally, one liter of water orally and oral administration of a vasopressin analogue called Minirin© (desmopressin, 60 µg), a loop diuretic called Furix© (furosemide, 40 mg) or one liter water orally and eight tablets of Resorb© which is a rehydration therapy. The multiple treatments and the fixed protocol are confounders and support the repetition of these experiments with a more suitable design. 1.2. Rationale for conducting this study The medical relevance of these experimental results is still unclear because of the short duration of four hours. With more experimental support, it is possible that this strategy could be used to create potent diuretics. It is also possible that long-term body weight loading could decrease body weight in a different way, especially by decreasing fat mass. This mechanism could therefore be used to create potent drugs for obesity. 1.3. Risk/Benefit evaluation In general this is a study with few risks. The weight vests used in this experiment are in daily use by thousands of people during exercise . During the experiment with medical students only one of the students experienced an adverse event. This student experienced mild dizziness which subsided within a few minutes after removing the weight vest and sitting down. To further minimize the risks in our future study the investigatorshave decided to include only healthy research subjects consuming no medications. The investigators will also have medically trained personnel available during the study and perform it in close vicinity to the Sahlgrenska University Hospital. Blood sampling can be experienced as somewhat uncomfortable by a few individuals. However it is generally free from complications. In some subjects, there may be small local bruising or inflammation. In summary the investigators believe the risks to be very low compared to the potential of exploring a new physiological mechanism with potentially important applications such as new diuretics or anti-obesity medicine.
  2. STUDY DESIGN AND PROCEDURES

The study is executed with all 15 study subjects over three study days with one week between each study day. In order to decrease the variation of the measurement values and increase the power of the study cross-over study design will be used. The study subjects will on one of the days wear a weight vest with 10 % of body weight in the standing position, on one of the days the same study subject will wear a weight vest with 1 % of body weight in the standing position and on one of the days the same study subject will wear a weight vest with 1 % of body weight in the sitting position.

Hence, three procedures are included in the study. Each of the procedure corresponds to a separate day.

Procedure 1: Wearing a weight vest with 10 % of body weight standing for seven hours. The study subject is allowed to sit for 10 minutes each hour. The reason for this is because it has been considered that the effect may be transmitted by weight loading of the lower extremities.

Procedure 2: Wearing a weight vest with 1 % of body weight standing for seven hours. The study subject is allowed to sit for 10 minutes each hour.

Procedure 3: Wearing a weight vest with 1 % of body weight sitting for seven hours. This is a control group without loading of the lower extremities. This is also the normal working position for many sedentary jobs (e.g. office workers) and why this is of special interest for further investigation. There is a large body of investigative literature showing the negative health consequences of the sitting working position.

Blood drawing will be performed with a peripheral venous catheter of the smallest size. Furthermore there will be several steps each day which will be uniform for each of the procedures.

Time point 1 (0 h): "Oral water load"

The catheter will be placed by an experienced nurse from Gothia Forum and is removed seven hours later when the procedure day is finished. Study proceedings and record keeping will be told to the research subject before the experiment officially starts.

Just before the experiment starts the study subject will drink 5 ml of water per kg body weight. For example, if the study subject weighs 70 kg (no weight vest), he or she will drink 350 ml of water.

To maintain a normal hydration level and urine production the study subject will continue to replace with fluids during the experiment. The volume of fluids that will be replaced will be equal to the amount of lost urine volume. If for example the study subject loses 100 ml urine he or she will drink of 100 ml water before continuing the experiment. By this method a urine production of approximately 200 ml per hour is maintained which is more than enough to perform all the required urine measurements.

This approach mimics physiological conditions wherein urinary losses are matched by water intake. It will avoid water intake in excess of replacement amounts which, in some circumstances, is viewed as treatment.

It is then decided by dice throw if a study subject will start with procedure 1, 2 or 3. When two of the procedure groups are full, with five individuals in each of them, the rest is transferred to the last procedure group. Rotation between the procedures occurs in random. Each study subject will have one week between performing each procedure.

The study subjects will empty their urine bladder just before the study starts. The study subjects start with five minutes separation to avoid congestioin to the toilets. The study starts when a study subject put on a weight vest.

Time Point 2 (0-7 h): Measurements and blood drawing

This time period consists of the part from when the study subject puts on the weight vest until the he or she takes it off.

The study subject shall each hour collect his or her urine volume in a specially designated measurement cup. The Urine Volume is noted. 10 ml of the urine are then used to measure the electrolyte concentration. Another 10 ml of urine is saved for further analyses at the Sahlgrenska University central lab. These analyses are routine but samples may be stored for a few days before the measurement takes place. This depends on when the central lab can accept our samples and on their specific working load. Sample storage and handling will be performed according to the central lab recommendations. The samples will at maximum be frozen down once at a temperature of -80°C.

When the urine measurements are complete the study subject will have five minutes to relax before measuring his or her heart rate and blood pressure. Heart rate and blood pressure are both measured standing and sitting with digital blood pressure monitors for quick and reliable values.

Blood will be drawn four times. The samples will be analyzed as soon as possible after each procedure day. Some analyses will be at the Sahlgrenska Academy directly, others will be delivered to Sahlgrenska University central lab (please see section 6.1 for details). These analyses are routine but samples may be stored for a few days before the measurement takes place. This depends on when the central lab can accept our samples and on their specific working load. Sample storage and handling will be performed according to the central labs recommendations.

Time point 3 (7 h -): The experiment is finished

Weight vest and peripheral venous catheter are removed. A procedure protocol is handed in from the study subject to the investigator who confirms its completeness. . The procedure protocol is either handed in digitally by uploading an excel file or handed in printed out.

Conditions
Obesity, Edema
Being tested
Heavy Casall HIT weight vest, Standing, Water load, Sitting, Light Casall HIT weight vest
Keywords
Obesity, Loading, Edema, Urine
Medical subject headings
Obesity, Edema

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Heavy Casall HIT weight vestOther

    A weight west with a weight of 10 % compared to the study subject

  • StandingBehavioural

    Study subjects will be standing for at least 50 minutes every hour

  • Water loadDietary supplement

    Study subjects will drink 5 ml per kg body weight at the start of experiment and continue drinking the same volume as excreted by the kidneys during the experiment

  • SittingBehavioural

    Study subjects will be sitting for at least 50 minutes of every hour

  • Light Casall HIT weight vestOther

    A weight west with a weight of 1 % compared to the study subject

Study groups in NCT03213717
Study groupRoleWhat they receive
Procedure 1ExperimentalWearing a weight vest with 10 % of body weight standing for seven hours. The study subject is allowed to sit for 10 minutes each hour. The reason for this is because it has been considered that the effect may be transmitted by weight loading of the lower extremities.
Receives: Other: Heavy Casall HIT weight vest; Behavioral: Standing; Dietary Supplement: Water load
Procedure 2Active comparatorWearing a weight vest with 1 % of body weight standing for seven hours. The study subject is allowed to sit for 10 minutes each hour.
Receives: Behavioral: Standing; Dietary Supplement: Water load; Other: Light Casall HIT weight vest
Procedure 3Active comparatorWearing a weight vest with 1 % of body weight sitting for seven hours. This is a control group without loading of the lower extremities. This is also the normal working position for many sedentary jobs (e.g. office workers) and why this is of special interest for further investigation. There is a large body of investigative literature showing the negative health consequences of the sitting working position.
Receives: Dietary Supplement: Water load; Behavioral: Sitting; Other: Light Casall HIT weight vest

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sodium concentration

    In urine

    Measured: 7 hours from start

Secondary outcomes (17)
  1. Urine Volume

    ml

    Measured: 7 hours from start

  2. Potassium concentration

    in urine

    Measured: 7 hours from start

  3. Chloride concentration

    in urine

    Measured: 7 hours from start

  4. Calcium concentration

    in urine

    Measured: 7 hours from start

  5. Creatinine

    in urine

    Measured: 7 hours from start

  6. pH

    in urine

    Measured: 7 hours from start

  7. Sodium

    in serum

    Measured: 6.5 hours from start

  8. Potassium

    in serum

    Measured: 6.5 hours from start

  9. Chloride

    in serum

    Measured: 6.5 hours from start

  10. Creatinine

    in serum

    Measured: 6.5 hours from start

  11. Lipocalin2

    in serum

    Measured: 6.5 hours from start

  12. Osteocalcin

    in serum

    Measured: 6.5 hours from start

  13. FGF23

    in serum

    Measured: 6.5 hours from start

  14. Sclerostin

    in serum

    Measured: 6.5 hours from start

  15. Glucose

    in whole blood

    Measured: 6.5 hours from start

  16. Blood pressure

    Systolic and Diastolic (mmHg)

    Measured: 7 hours from start

  17. Heart Rate

    bpm

    Measured: 7 hours from start

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2017
  2. Study start13 Jun 2017
  3. Primary completion4 Jul 2017
  4. Study completion4 Jul 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
The study is executed with all 15 study subjects over three study days with one week between each study day. In order to decrease the variation of the measurement values and increase the power of the study we will use a cross-over study design. The study subjects will on one of the days wear a weight vest with 10 % of body weight in the standing position, on one of the days the same study subject will wear a weight vest with 1 % of body weight in the standing position and on one of the days the same study subject will wear a weight vest with 1 % of body weight in the sitting position. Hence, three procedures are included in the study. Each of the procedure corresponds to a separate day.
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03213717
Sponsor's protocol ID
EBU
Acronym
EBU
Status last verified
Apr 2025
First submitted
4 Jul 2017
Last updated
2 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Heavy Casall HIT weight vest, Standing and Water load in people with Obesity and Edema, run by Göteborg University at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sodium concentration (time frame: 7 hours from start). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in